ArticlePharmaceuticals (Basel, Switzerland)2021

Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections.

Goeun Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.